http://www.biomarin.com
BioMarin Pharmaceutical Inc. Company Intro
Industry
Healthcare
BioMarin Pharmaceutical Inc. Headquaters
770 Lindaro Street
San Rafael,94901
United States
BioMarin Pharmaceutical Inc. Share price
14 Sep 2022 08:47 GMT
$89.51
-0.73 (-0.81 %)
BioMarin Pharmaceutical Inc. Market cap
$16.051 B
WMC RANKING
2023
BioMarin Pharmaceutical Inc. # 8
BiotechnologyLatest BioMarin Pharmaceutical Inc. News
07 Feb 2023
BioMarin to Host Fourth Quarter and Full-Year 2022 Financial ...
SOURCE BioMarin Pharmaceutical Inc. © 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
07 Feb 2023
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares ...
BioMarin Pharmaceutical, Inc engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and...
07 Feb 2023
USC Stem Cell Research Paves Way for ALS Treatment
In the Cell Stem Cell study, co-first authors Linares and Yichen Li found that several of the most ... and is a paid employee of BioMarin Pharmaceutical.
WMC Market Score
WMC Market to Revenue Score
BioMarin Pharmaceutical Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| BioMarin Pharmaceutical Inc. | USD | $1,844,487 | $1,421,184 | $795,090 | $160,510B | 8 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total BioMarin Pharmaceutical Inc. Social Followers vs Top 4 Industry Competitors
BioMarin Pharmaceutical Inc. Post vs Top 4 Industry Competitors
BioMarin Pharmaceutical Inc. Digital Footprint By Size vs Top 4 Industry Competitors
BioMarin Pharmaceutical Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
BioMarin Pharmaceutical Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| BioMarin Pharmaceutical Inc. | 20.05 | 48.40 | 52.93 | 0 | 0 | 0 | 45.77 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
